EUVIMEDEUVIMED entdecken
Crossref

Enhanced eNOS/nitric oxide production by nebivolol interferes with TGF-β1/Smad3 signaling and collagen I deposition in the kidney after prolonged tacrolimus administration

Amany A Azouz, Mohamed A Tohamy, Fares E M Ali, Heba M Mahmoud

Life Sciences · 2024

DOI: 10.1016/j.lfs.2024.122995 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Sciences, 2024. Verfasst von Amany A Azouz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt. Electronic address: amany.azoz@pharm.bsu.…. Hauptthemen laut MEDLINE: Nebivolol, Smad3 Protein, Nitric Oxide, Tacrolimus. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Faculty of Veterinary Medicine, Cairo University, Faculty of Veterinary Medicine, Damanhour University, Beni-Suef University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: Tacrolimus is an effective immunosuppressant commonly used post-transplantation and in certain autoimmune diseases. However, its long-term administration is associated with renal fibrosis through transforming growth factor-beta/suppressor of mother against decapentaplegic (TGF-β/Smad) signaling that could be partly attributed to endothelial dysfunction alongside decreased nitric oxide (NO) release. Our study aimed to investigate the prospective renal anti-fibrotic effect of enhanced NO production by nebivolol against tacrolimus-stimulated TGF-β1/Smad3 signaling. MATERIALS AND METHODS: To illustrate the proposed mechanism of nebivolol, Nω-nitro-L-arginine methyl ester (L-NAME); nitric oxide synthase inhibitor; was co-administered with nebivolol. Rats were treated for 30 days as control, tacrolimus, tacrolimus/nebivolol, tacrolimus/L-NAME, and tacrolimus/nebivolol/L-NAME groups. KEY FINDINGS: Our results revealed that renal NO content was reduced in tacrolimus-treated rats, while treatment with tacrolimus/nebivolol enhanced NO content via up-regulated endothelial nitric oxide synthase (eNOS), but down-regulated inducible nitric oxide synthase (iNOS) expression. That participated in the inhibition of TGF-β1/Smad3 signaling induced by tacrolimus, where the addition of L-NAME abolished the defensive effects of nebivolol. Subsequently, the deposition of collagen I and alpha-smooth muscle actin (α-SMA) was retarded by nebivolol, emphasized by reduced Masson's trichrome staining. In accordance, there was a strong negative correlation between eNOS and both TGF-β1 and collagen I protein expression. The protective effects of nebivolol were further confirmed by the improvement in kidney function biomarkers and histological features. SIGNIFICANCE: It can be suggested that treatment with nebivolol along with tacrolimus could effectively suppress renal TGF-β1/Smad3 fibrotic signaling via the enhancement of endothelial NO production, thus curbing renal fibrosis development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NebivololSmad3 ProteinNitric OxideTacrolimusTransforming Growth Factor beta1Nitric Oxide Synthase Type IIISignal TransductionKidneyCollagen Type IAnimalsRatsMaleImmunosuppressive AgentsFibrosisNG-Nitroarginine Methyl EsterRats, WistarRats, Sprague-Dawley

Stichwörter der Autor:innen

NebivololNitric oxideTGF-β1/Smad3/collagen I signalingTacrolimus-induced renal fibrosiseNOS/iNOS

Substanzen

NebivololSmad3 ProteinNitric OxideTacrolimusTransforming Growth Factor beta1Nitric Oxide Synthase Type IIICollagen Type IImmunosuppressive AgentsSmad3 protein, ratNos3 protein, rat

Autor:innen und Institutionen

  • Department of Pharmacology & Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt. Electronic address: amany.azoz@pharm.bsu.edu.eg.
  • Department of Biochemistry, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt.
  • Department of Pharmacology & Toxicology, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Assiut 71524, Egypt; Michael Sayegh, Faculty of Pharmacy, Aqaba University of Technology, Aqaba 77110, Jordan.
  • Department of Pharmacology & Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt.

Förderung

  • Faculty of Veterinary Medicine, Cairo University
  • Faculty of Veterinary Medicine, Damanhour University
  • Beni-Suef University

Zitieren

APA

Azouz, A. A., Tohamy, M. A., Ali, F. E. M., & Mahmoud, H. M. (2024). Enhanced eNOS/nitric oxide production by nebivolol interferes with TGF-β1/Smad3 signaling and collagen I deposition in the kidney after prolonged tacrolimus administration. Life Sciences. https://doi.org/10.1016/j.lfs.2024.122995

Vancouver

Azouz AA, Tohamy MA, Ali FEM, Mahmoud HM. Enhanced eNOS/nitric oxide production by nebivolol interferes with TGF-β1/Smad3 signaling and collagen I deposition in the kidney after prolonged tacrolimus administration. Life Sciences. 2024. doi:10.1016/j.lfs.2024.122995

BibTeX
@article{Azouz2024,
  author = {Azouz, Amany A and Tohamy, Mohamed A and Ali, Fares E M and Mahmoud, Heba M},
  title = {Enhanced eNOS/nitric oxide production by nebivolol interferes with TGF-β1/Smad3 signaling and collagen I deposition in the kidney after prolonged tacrolimus administration},
  journal = {Life Sciences},
  year = {2024},
  doi = {10.1016/j.lfs.2024.122995}
}
Kostenlos starten →